Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
2.
Aten Primaria ; 27(6): 403-7, 2001 Apr 15.
Artigo em Espanhol | MEDLINE | ID: mdl-11334577

RESUMO

OBJECTIVES: To quantify the monthly inter-clinic rate (MIR), the medical reports received, their quality and the period of delay until the first second-level consultation. DESIGN: Cross-sectional, descriptive study. SETTING: Rural health centre. SAMPLE: 498 first consultations requested of the second level by three family medicine lists between June and November 1999. 132 were excluded for presenting a criterion of exclusion (consultations within the second level, check-ups, appointments missed by the patient and consultations that could not be recorded), which left a sample size of 366. MEASUREMENTS AND RESULTS: Mean MIR was 34 . Ophthalmology (21.9%), gynaecology (15.3%) and traumatology (13.9%) were the most commonly requested services. 69 reports (18.8%) were received, leaving 297 (81.2%) not received. Pneumology (100%) and internal medicine (81.8%) services sent through most reports, whereas haematology and rehabilitation (0%) sent through least. The mean score on the reports was 8 +/- 2 out of a maximum of 10. Mean delay was 73 +/- 46 days. CONCLUSION: The monthly inter-clinic rate found was within the figures cited in the literature. The percentage of reports received was way below what was found in the literature, but their quality was good.


Assuntos
Prontuários Médicos/normas , Encaminhamento e Consulta , Estudos Transversais , Feminino , Humanos , Relações Interprofissionais , Masculino
3.
Aten. prim. (Barc., Ed. impr.) ; 27(6): 403-407, abr. 2001.
Artigo em Es | IBECS | ID: ibc-2219

RESUMO

Objetivos. Cuantificar la tasa de interconsulta mensual (TIM), porcentaje de informes médicos recibidos, calidad de éstos y tiempo de demora de la primera consulta al segundo nivel. Diseño. Estudio descriptivo, transversal. Emplazamiento. Centro de salud rural. Muestra. Las 498 primeras consultas solicitadas al segundo nivel de 3 cupos de médicos de familia desde junio a noviembre de 1999. Se excluyeron 132 por presentar algún criterio de exclusión (consultas entre el segundo nivel, revisiones, consultas a las que el paciente no acudió y aquellas que no se pudieron registrar), quedando un tamaño muestral de 366 (n).Mediciones y resultados. La TIM media fue del 34 . Los servicios de oftalmología (21,9 por ciento), ginecología (15,3 por ciento) y traumatología (13,9 por ciento) fueron los más solicitados. Se recibieron 69 informes (18,8 por ciento), quedando 297 (81,2 por ciento) sin recibir. Los servicios de neumología (100 por ciento) y medicina interna (81,8 por ciento) fueron los que más informes remitieron, mientras que hematología y rehabilitación (0 por ciento) fueron los que menos. La puntuación media de los informes fue de 8 ñ 2 sobre un máximo de 10. La demora media fue de 73 ñ 46 días. Conclusión. La TIM se encuentra entre los valores descritos en la bibliografía. El porcentaje de informes recibidos es muy inferior a lo hallado en la bibliografía, pero su calidad es buena (AU)


Assuntos
Masculino , Feminino , Humanos , Encaminhamento e Consulta , Estudos Transversais , Relações Interprofissionais , Prontuários Médicos
4.
Rev Esp Enferm Dig ; 79(3): 219-21, 1991 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-2043409

RESUMO

We report a case of a 5-aminosalicylate-induced pancreatitis in a patient with Crohn's disease. These findings suggest that some side effects, traditionally thought to be related to sulphafapyridine, are really due to 5-aminosalicylate. The good prognosis of this rare complication depends on the early withdrawal of the drug. Therefore the degree of the clinical suspicion plays a essential role in the appropriate diagnosis, but a challenge with mesalazine must be carried out in those patients in which other causes of pancreatitis could not be excluded.


Assuntos
Ácidos Aminossalicílicos/efeitos adversos , Pancreatite/induzido quimicamente , Doença Aguda , Adulto , Doença de Crohn/complicações , Doença de Crohn/tratamento farmacológico , Quimioterapia Combinada , Feminino , Humanos , Mesalamina , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA